课题基金 / 基金详情

New strategy for cancer therapy using Hi-resolution microsatellite instability analysis and Real-time quantitative reverse transcriptase polymerase reaction

New strategy for cancer therapy using Hi-resolution microsatellite instability analysis and Real-time quantitative reverse transcriptase polymerase reaction
利用高分辨率微卫星不稳定性分析和实时定量逆转录酶聚合酶反应的癌症治疗新策略
批准号:
12557101
负责人:
MAEHARA Yoshihiko
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

MAEHARA Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
微小转移;采用实时定量逆转录酶聚合酶链反应(RT-PCR)检测骨髓和外周血中弥散性癌细胞。我们比较了20个细胞系的CEA、CK18、CK19和CK20的表达,以选择最合适的表达。通过对13名健康志愿者外周静脉血中CK 18 mRNA表达的分析,我们发现CK 18 mRNA的表达远低于癌细胞系。然而,所有样品中的表达水平也可以用常规RT-PCR检测到。因此,不仅定性,而且定量分析靶mRNA对检测微转移很重要。定量RT-PCR方法将比较目标基因表达水平可能存在的差异。对于临床应用,还需要进一步的研究。Microsalellite不稳定;我们采用高分辨率荧光微卫星分析(HFRMA)对800多例散发性乳腺癌、胃癌、结肠癌、肺癌和肝癌患者进行了研究。在该系统中,为了提高聚合酶链反应产物的重现性、电泳的迁移准确性和检测系统的特性,制备了几种装置。该系统观测到的微卫星变化可分为A型和B型,A型微卫星序列在有限的位点上变化相对较小,B型微卫星序列变化剧烈且分布广泛。前者被认为与DNA错配修复(MMR)中的异常活动有关。
英文摘要
Micrometastasis; Real time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect disseminated cancer cells in bone marrow and peripheral blood. We compared CEA, CK18, CK19 and CK20 expression using 20 of cell lines in order to select the most appropriate. In an analysis of CK 18 mRNA expression in peripheral venous blood in 13 healthy volunteers, we found that CK 18 mRNA was much less expressed than in cancer cell lines. However, the expression in all samples was at a level which was also detected using conventional RT-PCR. It would thus seem that not only qualitative, but also quantitative analysis, of the target mRNA is important to detect micrometastasis. Quantitative RT-PCR methods will make comparisons of the possible differences in expression levels of the target gene. For clinical applications, much further study is needed.Microsalellite Instability; Using high-resolution fluorescent microsatellite analysis (HFRMA), we studied over 800 patients with sporadic breast, gastric, colon, lung and liver cancer. In this system, several devices were prepared to improve reproducibility of polymerase chain reaction products, migration accuracy of electrophoresis, and characteristics of the detection system. All the microsatellite changes observed in this system can be classified into two types: type A with relatively small changes in microsatellite sequences observed in limited loci and type B with drastic and widely dispersed changes. The former was thought to be connected to abnormal activity in DNA mismatch repair (MMR).
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
Maehara Y, et al.: "Diagnosis and treatment for familial gastric cancer."29(4). 523-531 (2002)
Maehara Y 等人:“家族性胃癌的诊断和治疗。”29(4)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tokunaga E, et al.: "Application of quantitative RT-PCR using "TaqMan" technology to evaluate the expression of CK 18 mRNA in various cell lines."J Exp Clin cancer Res.. 19(3). 375-381 (2000)
Tokunaga E 等人:“应用定量 RT-PCR 使用“TaqMan”技术评估各种细胞系中 CK 18 mRNA 的表达。”J Exp Clin cancer Res. 19(3)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oda S, et al.: "Microsatellite instability in cancer : what problems remain unanswered?"Surgery. 131(1Suppl). S55-S62 (2002)
Oda S 等人:“癌症中的微卫星不稳定性:还有哪些问题尚未解决?”外科手术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Development of the the innovative treatment and the proposal of the Self-niche hypothesis in refractory cancer
    • 批准号:
      16K15620
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    Pre-clinical application of an innovative therapy, "BioKnife", to malignant pleural mesothelioma
    • 批准号:
      24249071
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.63万
    • 财政年份:
      2012
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    New cancer treatment focusing on genetic instability of the cancer stem cell
    • 批准号:
      24659614
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    Development of'BioKnife', a uPA-targeted oncolytic Sendai virus to treat intractable malignancies.
    • 批准号:
      22659246
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    海外基金